CD8 T cells could regulate endocytic recycling of PD-1 and exert synergistic effects with anti-PD-1 therapy in hepatocellular carcinoma (63), and inducing immunogenic ferroptosis in cancer cells also potentiates anti-PD-1 therapy (64), highlighting a promising strategy for cancer immunotherapy. Here, PDCD1 is linked to cancer.